Enlivex Therapeutics Ownership | Who Owns Enlivex Therapeutics?


OverviewForecastFinancialsChart

Enlivex Therapeutics Ownership Summary


Enlivex Therapeutics is owned by 13.12% institutional investors, 5.74% insiders, and 81.14% retail investors. Armistice capital is the largest institutional shareholder, holding 9.08% of ENLV shares. Dolphin 90/10 IL is the top mutual fund, with 0.20% of its assets in Enlivex Therapeutics shares.

ENLV Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEnlivex Therapeutics13.12%5.74%81.14%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Armistice capital1.70M9.08%$2.41M
Morgan stanley244.89K1.31%$347.75K
Renaissance71.69K0.38%$101.80K
Xtx topco24.82K0.13%$35.24K
Goldman sachs group11.43K0.06%$16.23K
Geode capital management10.42K0.06%$14.80K
Wells fargo & company/mn9.18K0.05%$13.04K
Group one trading5.75K0.03%$8.16K
Steward partners investment advisory3.00K0.02%$4.26K
Activest wealth management1.00K0.01%$1.42K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Armistice capital1.70M0.03%$2.41M
Xtx topco24.82K0.00%$35.24K
Activest wealth management1.00K0.00%$1.42K
Renaissance71.69K0.00%$101.80K
Red tortoise150.000.00%$213.00
Srs capital advisors615.000.00%$874.00
Steward partners investment advisory3.00K-$4.26K
Susquehanna group, llp---
Jpmorgan chase231.00-$328.00
Simplex trading---

Top Buyers

HolderShares% AssetsChange
Armistice capital1.70M0.03%1.70M
Morgan stanley244.89K-172.77K
Xtx topco24.82K0.00%24.82K
Goldman sachs group11.43K-11.43K
Renaissance71.69K0.00%1.80K

Top Sellers

HolderShares% AssetsChange
Susquehanna group, llp---67.94K
Citadel advisors---55.52K
Simplex trading---18.26K
Jpmorgan chase231.00--6.92K
Ubs group16.00--3.05K

New Positions

HolderShares% AssetsChangeValue
Armistice capital1.70M0.03%1.70M$2.41M
Xtx topco24.82K0.00%24.82K$35.24K
Goldman sachs group11.43K-11.43K$16.23K
Activest wealth management1.00K0.00%1.00K$1.42K
Srs capital advisors615.000.00%615.00$874.00

Sold Out

HolderChange
Qube research-1.00
Barclays-1.00K
Simplex trading-18.26K
Citadel advisors-55.52K
Susquehanna group, llp-67.94K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20242110.53%2,564,82323.06%1310.59%912.50%3-40.00%
Jun 30, 202419-2,084,178539.03%11360.97%833.33%5150.00%
Mar 31, 2024195.56%326,14673.06%1170.98%6-14.29%2-33.33%
Dec 31, 202318-188,457-23.18%157.74%7133.33%3-25.00%
Sep 30, 202318-14.29%245,309-14.64%155.00%3-25.00%4-42.86%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dolphin 90/10 IL43.48K0.20%-
MTF TR TA-Growth38.06K0.18%8.57K
IBI Mehaka TA-Growth11.37K0.05%3.37K
Fidelity Nasdaq Composite Index10.42K0.05%-
Dolphin Flexible7.92K0.04%-
I.B.I 90/105.75K0.03%-
Harel HTF TA All-Share IL3.85K0.02%961.00
I.B.I Government + 10% IL3.00K0.01%-
Dolphin75/25 IL787.000.00%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 09, 2015Murray Michael Anthony former SVP - OperationsSell$156.76K

ENLV Ownership FAQ


Who Owns Enlivex Therapeutics?

Enlivex Therapeutics shareholders are primarily institutional investors at 13.12%, followed by 5.74% insiders and 81.14% retail investors. The average institutional ownership in Enlivex Therapeutics's industry, Biotech Stocks , is 47.04%, which Enlivex Therapeutics falls below.

Who owns the most shares of Enlivex Therapeutics?

Enlivex Therapeutics’s largest shareholders are Armistice capital (1.7M shares, 9.08%), Morgan stanley (244.89K shares, 1.31%), and Renaissance (71.69K shares, 0.38%). Together, they hold 10.77% of Enlivex Therapeutics’s total shares outstanding.

Does Blackrock own Enlivex Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Enlivex Therapeutics.

Who is Enlivex Therapeutics’s biggest shareholder by percentage of total assets invested?

Armistice capital is Enlivex Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 1.7M Enlivex Therapeutics shares, valued at 2.41M$.

Who is the top mutual fund holder of Enlivex Therapeutics shares?

Dolphin 90/10 IL is the top mutual fund holder of Enlivex Therapeutics shares, with 0.20% of its total shares outstanding invested in 43.48K Enlivex Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools